U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06833814) titled 'DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations' on Feb. 07.
Brief Summary: Patients with severe asthma frequently experience exacerbations of their disease. The heterogeneity of asthma exacerbations represents a major challenge for patients and healthcare providers, making treatment difficult. Current guidelines recommend varying doses of short-term oral corticosteroids (OCS) as first-line treatment for asthma exacerbations. However, studies supporting the optimal dose of OCS to treat asthma exacerbations are rare.
This study aims to evaluate the feasibility, acceptability, and safety of a randomized...